Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Pharmacogn Rev
2015 Jan 01;917:1-11. doi: 10.4103/0973-7847.156307.
Show Gene links
Show Anatomy links
Sweetgum: An ancient source of beneficial compounds with modern benefits.
Lingbeck JM
,
O'Bryan CA
,
Martin EM
,
Adams JP
,
Crandall PG
.
???displayArticle.abstract???
Sweetgum trees are large, deciduous trees found in Asia and North America. Sweetgum trees are important resources for medicinal and other beneficial compounds. Many of the medicinal properties of sweetgum are derived from the resinous sap that exudes when the outer bark of the tree has been damaged. The sap, known as storax, has been used for centuries to treat common ailments such as skin problems, coughs, and ulcers. More recently, storax has proven to be a strong antimicrobial agent even against multidrug resistant bacteria such as methicillin-resistant Staphylococcus aureus. In addition to the sap, the leaves, bark, and seeds of sweetgum also possess beneficial compounds such as shikimic acid, a precursor to the production of oseltamivir phosphate, the active ingredient in Tamiflu®-an antiviral drug effective against several influenza viruses. Other extracts derived from sweetgum trees have shown potential as antioxidants, anti-inflammatory agents, and chemopreventive agents. The compounds found in the extracts derived from sweetgum sap suppress hypertension in mice. Extracts from sweetgum seeds have anticonvulsant effects, which may make them suitable in the treatment of epilepsy. In addition to the potential medicinal uses of sweetgum extracts, the extracts of the sap possess antifungal activity against various phytopathogenic fungi and have been effective treatments for reducing nematodes and the yellow mosquito, Aedes aegypti, populations thus highlighting the potential of these extracts as environment-friendly pesticides and antifungal agents. The list of value-added products derived from sweetgum trees can be increased by continued research of this abundantly occurring tree.
An,
A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
2009, Pubmed
An,
A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
2009,
Pubmed
Bradley,
Star role for bacteria in controlling flu pandemic?
2005,
Pubmed
Carson,
Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties.
2006,
Pubmed
Dat,
Oleanane triterpenoids with inhibitory activity against NFAT transcription factor from Liquidambar formosana.
2004,
Pubmed
El-Readi,
Variations of the chemical composition and bioactivity of essential oils from leaves and stems of Liquidambar styraciflua (Altingiaceae).
2013,
Pubmed
Fukuda,
Cancer chemopreventive activity of lupane- and oleanane-type triterpenoids from the cones of Liquidamber styraciflua.
2005,
Pubmed
Gullett,
Cancer prevention with natural compounds.
2010,
Pubmed
Guo,
Sedative and anticonvulsant activities of styrax after oral and intranasal administration in mice.
2011,
Pubmed
Gurbuz,
Characterization of volatiles and anti-ulcerogenic effect of Turkish sweetgum balsam (Styrax liquidus).
2013,
Pubmed
Jeong,
Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury.
1999,
Pubmed
Johansson,
Shikimic acid production by a modified strain of E. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions.
2005,
Pubmed
Kim,
Nematicidal activity of plant essential oils and components from coriander (Coriandrum sativum), Oriental sweetgum (Liquidambar orientalis), and valerian (Valeriana wallichii) essential oils against pine wood nematode (Bursaphelenchus xylophilus).
2008,
Pubmed
Konno,
Antihepatotoxic principles of Liquidambar formosana fruits.
1988,
Pubmed
Krämer,
Metabolic engineering for microbial production of shikimic acid.
2003,
Pubmed
Martin,
Sweetgum (Liquidambar styraciflua L.): extraction of shikimic acid coupled to dilute acid pretreatment.
2010,
Pubmed
Mittal,
Reactive oxygen species in inflammation and tissue injury.
2014,
Pubmed
Ocsel,
Effects of oriental sweet gum storax on porcine wound healing.
2012,
Pubmed
Ohno,
Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension.
2008,
Pubmed
PLOUVIER,
[On the study of quinic and shikimic acids in certain Anacardiaceae].
1960,
Pubmed
Sakai,
New cytotoxic oleanane-type triterpenoids from the cones of Liquidamber styraciflua.
2004,
Pubmed
Sağdiç,
A study on inhibitory effects of Siğla tree (Liquidambar orientalis Mill. var. orientalis) storax against several bacteria.
2005,
Pubmed
Sova,
Antioxidant and antimicrobial activities of cinnamic acid derivatives.
2012,
Pubmed
Tan,
Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.
2003,
Pubmed
Tian,
Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
2011,
Pubmed
Topal,
Chemical compositions and antioxidant properties of essential oils from nine species of Turkish plants obtained by supercritical carbon dioxide extraction and steam distillation.
2008,
Pubmed
Wenger,
The Sprouting of Sweetgum in Relation to Season of Cutting and Carbohydrate Content.
1953,
Pubmed
Wyllie,
The Leaf Oil of Liquidambar styraciflua.
1989,
Pubmed
Yang,
Pentacyclic triterpenes from the resin of Liquidambar formosana.
2011,
Pubmed
